Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure
暂无分享,去创建一个
Y. Izumi | K. Shimada | M. Yoshiyama | A. Hanatani | M. Terashima | Kenji Matsumoto | S. Ehara | Yasuhiro Nakamura | T. Hasegawa | M. Takagi
[1] N. Hagiwara,et al. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes , 2013, Heart and Vessels.
[2] D. Kass,et al. Pathological Cardiac Hypertrophy Alters Intracellular Targeting of Phosphodiesterase Type 5 From Nitric Oxide Synthase-3 to Natriuretic Peptide Signaling , 2012, Circulation.
[3] M. Marletta,et al. Structure and regulation of soluble guanylate cyclase. , 2012, Annual review of biochemistry.
[4] F. Fedele,et al. Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging , 2012, Circulation.
[5] L. R. Potter,et al. Guanylyl cyclase structure, function and regulation. , 2011, Cellular signalling.
[6] C. von Birgelen,et al. Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast enhancement cardiovascular magnetic resonance imaging study , 2011, Journal of Cardiovascular Magnetic Resonance.
[7] K. Katahira,et al. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. , 2010, Journal of the American College of Cardiology.
[8] S. Kunimoto,et al. Detection of coronary artery disease by free-breathing, whole heart coronary magnetic resonance angiography: our initial experience , 2009, Heart and Vessels.
[9] Kan Takeda,et al. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. , 2006, Journal of the American College of Cardiology.
[10] Bob S. Hu,et al. Noninvasive assessment of coronary vasodilation using magnetic resonance angiography. , 2005, Journal of the American College of Cardiology.
[11] Paramate Horkaew,et al. Intra‐ and interstudy reproducibility of coronary artery diameter measurements in magnetic resonance coronary angiography , 2004, Journal of magnetic resonance imaging : JMRI.
[12] EikeNagel,et al. Noninvasive Determination of Coronary Blood Flow Velocity With Cardiovascular Magnetic Resonance in Patients After Stent Deployment , 2003 .
[13] E. Wellnhofer,et al. Noninvasive Determination of Coronary Blood Flow Velocity With Cardiovascular Magnetic Resonance in Patients After Stent Deployment , 2003, Circulation.
[14] René M. Botnar,et al. Coronary MR angiography clinical applications and potential for imaging coronary artery disease. , 2003, Magnetic resonance imaging clinics of North America.
[15] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[16] Jeroen J. Bax,et al. Coronary magnetic resonance angiography: technical developments and clinical applications. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[17] D. Gardner,et al. N ATRIURETIC P EPTIDES , 1998 .
[18] M. Currie,et al. Correlation between vascular and cellular responses to atrial natriuretic peptide and to sodium nitroprusside. , 1994, Life sciences.
[19] M. Kinoshita,et al. Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries. , 1993, European journal of pharmacology.
[20] P. Merlet,et al. Hemodynamic Response to Intracoronary Infusion of Atrial Natriuretic Factor in Patients with Normal or Altered Left Ventricular function , 1991, Journal of cardiovascular pharmacology.
[21] A. Takeshita,et al. Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries. , 1991, Japanese circulation journal.
[22] F. Cobb,et al. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. , 1989, Circulation.
[23] J. Horowitz,et al. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. , 1989, The Journal of pharmacology and experimental therapeutics.
[24] D. Gardner,et al. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. , 1988, The American journal of physiology.
[25] F. Cobb,et al. Effects of Atrial Natriuretic Peptide on Proximal Epicardial Coronary Arteries and Coronary Blood Flow in Conscious Dogs , 1987, Circulation research.
[26] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[27] F. Murad,et al. Cyclic guanosine monophosphate as a mediator of vasodilation. , 1986, The Journal of clinical investigation.
[28] F. Murad,et al. Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta. , 1985, European journal of pharmacology.
[29] F. Murad,et al. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. , 1984, The Journal of biological chemistry.
[30] J. Parker,et al. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy. , 1984, The American journal of cardiology.